Search research articles
Contact Us
Filters
Showing results (61-70 of 250) with videos related to
Page
of 25
Sort By:
Cancers
|
February 15, 2022
Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
Eun-Joo Park, Hyo-Jung Park, Kyung-Won Kim, et al.
Gastrointestinal Endoscopy
|
June 27, 2009
Verrucous carcinoma of the esophagus
Shin Na, Kee Don Choi, Changhoon Yoo, et al.
Annals of Hematology
|
December 25, 2010
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
Changhoon Yoo, Dae Ho Lee, Jeong Eun Kim, et al.
Future Oncology (London, England)
|
January 12, 2024
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, et al.
Journal of Hepatology
|
April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
Stephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Investigational New Drugs
|
September 17, 2013
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
Changhoon Yoo, Jeeyun Lee, Sun Young Rha, et al.
The American Journal of Surgical Pathology
|
August 1, 2020
Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis
Jisup Kim, Joo Young Kim, Eun Hye Oh, et al.
Frontiers in Oncology
|
April 6, 2026
Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOX
Jong Hyuk Lee, Yousun Ko, Seongwon Na, et al.
Journal of Breast Cancer
|
July 19, 2012
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy
Changhoon Yoo, Jin-Hee Ahn, Kyung Hae Jung, et al.
EJNMMI Research
|
June 17, 2020
Tumour-to-liver ratio determined by [<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
Yong-Il Kim, Changhoon Yoo, Seung Jun Oh, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 250) with videos related to
Sort By:
Page
of 25
Cancers
|
February 15, 2022
Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
Eun-Joo Park, Hyo-Jung Park, Kyung-Won Kim, et al.
Gastrointestinal Endoscopy
|
June 27, 2009
Verrucous carcinoma of the esophagus
Shin Na, Kee Don Choi, Changhoon Yoo, et al.
Annals of Hematology
|
December 25, 2010
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
Changhoon Yoo, Dae Ho Lee, Jeong Eun Kim, et al.
Future Oncology (London, England)
|
January 12, 2024
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, et al.
Journal of Hepatology
|
April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
Stephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Investigational New Drugs
|
September 17, 2013
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
Changhoon Yoo, Jeeyun Lee, Sun Young Rha, et al.
The American Journal of Surgical Pathology
|
August 1, 2020
Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis
Jisup Kim, Joo Young Kim, Eun Hye Oh, et al.
Frontiers in Oncology
|
April 6, 2026
Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOX
Jong Hyuk Lee, Yousun Ko, Seongwon Na, et al.
Journal of Breast Cancer
|
July 19, 2012
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy
Changhoon Yoo, Jin-Hee Ahn, Kyung Hae Jung, et al.
EJNMMI Research
|
June 17, 2020
Tumour-to-liver ratio determined by [<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
Yong-Il Kim, Changhoon Yoo, Seung Jun Oh, et al.
Page
of 25